Login Register Cart 0
Generic placeholder image

Current Cardiology Reviews

Editor-in-Chief

ISSN (Print): 1573-403X
ISSN (Online): 1875-6557

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Cardiovascular Symptoms, Dysautonomia, and Quality of Life in Adult and Pediatric Patients with Hypermobile Ehlers-Danlos Syndrome: A Brief Review

Author(s): Amanda Hertel*, William R. Black, Lindsey Malloy Walton, Julie R. Martin and Jordan T. Jones

Volume 20, Issue 1, 2024

Published on: 24 January, 2024

Article ID: e240124226070 Pages: 7

DOI: 10.2174/011573403X271096231203164216

Price: $65

Abstract

Background: Hypermobile Ehlers-Danlos Syndrome (hEDS) is a connective tissue disorder characterized by joint hypermobility and other systemic manifestations, such as cardiovascular symptoms, musculoskeletal pain, and joint instability. Cardiovascular symptoms, such as lightheadedness and palpitations, and types of dysautonomia, including postural orthostatic tachycardia syndrome (POTS), are frequently reported in adults with hEDS and have been shown to negatively impact quality of life (QoL).

Objective: This brief review will be an overview of co-occurring symptoms in POTS and hEDS to inform potential cardiovascular screening procedures.

Results: While many patients with hEDS report cardiovascular symptoms, few have structural abnormalities, suggesting that dysautonomia is likely responsible for these symptoms. One validated screening measure for dysautonomia symptom burden is the Composite Autonomic Symptom Scale (COMPASS-31). Studies have found that adults with POTS, hEDS, and both POTS and hEDS have higher COMPASS-31 scores than the general population, suggesting a high symptom burden due to dysautonomia, which leads to impaired QoL.

Conclusion: While studies have examined cardiovascular symptoms and the impact of dysautonomia in adults with and without hEDS, there is scant literature on dysautonomia in pediatric patients with hEDS. Therefore, more studies on cardiovascular symptoms and dysautonomia, as they relate to the quality of life in pediatric patients with hEDS, are needed. This brief review summarizes the current literature on dysautonomia and cardiovascular symptoms in pediatric and adult populations with hEDS.

Graphical Abstract

[1]
Malfait F, Francomano C, Byers P, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 2017; 175(1): 8-26.
[http://dx.doi.org/10.1002/ajmg.c.31552] [PMID: 28306229]
[2]
Syx D, De Wandele I, Symoens S, et al. Bi-allelic AEBP1 mutations in two patients with Ehlers-Danlos syndrome. Hum Mol Genet 2019; 28(11): 1853-64.
[http://dx.doi.org/10.1093/hmg/ddz024] [PMID: 30668708]
[3]
Alazami AM, Al-Qattan SM, Faqeih E, et al. Expanding the clinical and genetic heterogeneity of hereditary disorders of connective tissue. Hum Genet 2016; 135(5): 525-40.
[http://dx.doi.org/10.1007/s00439-016-1660-z] [PMID: 27023906]
[4]
Blackburn PR, Xu Z, Tumelty KE, et al. Bi-allelic alterations in AEBP1 lead to defective collagen assembly and connective tissue structure resulting in a variant of Ehlers-Danlos syndrome. Am J Hum Genet 2018; 102(4): 696-705.
[http://dx.doi.org/10.1016/j.ajhg.2018.02.018] [PMID: 29606302]
[5]
Malfait F, Castori M, Francomano CA, Giunta C, Kosho T, Byers PH. The ehlers-danlos syndromes. Nat Rev Dis Primers 2020; 6(1): 64.
[http://dx.doi.org/10.1038/s41572-020-0194-9] [PMID: 32732924]
[6]
Yew KS, Kamps-Schmitt KA, Borge R. Hypermobile ehlers-danlos syndrome and hypermobility spectrum disorders. Am Fam Physician 2021; 103(8): 481-92.
[PMID: 33856167]
[7]
Tofts LJ, Simmonds J, Schwartz SB, et al. Pediatric joint hypermobility: A diagnostic framework and narrative review. Orphanet J Rare Dis 2023; 18(1): 104.
[http://dx.doi.org/10.1186/s13023-023-02717-2] [PMID: 37143135]
[8]
Cameron N. Can maturity indicators be used to estimate chronological age in children? Ann Hum Biol 2015; 42(4): 302-7.
[http://dx.doi.org/10.3109/03014460.2015.1032349] [PMID: 26073641]
[9]
Cavallo F, Mohn A, Chiarelli F, Giannini C. Evaluation of bone age in children: A mini-review. Front Pediatr 2021; 9: 580314.
[http://dx.doi.org/10.3389/fped.2021.580314] [PMID: 33777857]
[10]
Cech DJ, Martin ST. Skeletal system changes. In: Cech DJ, Martin ST, Eds. Functional movement development across the life span. (3rd ed.). Saint Louis: W.B. Saunders 2012; pp. 105-28.
[http://dx.doi.org/10.1016/B978-1-4160-4978-4.00006-5]
[11]
Tinkle B, Castori M, Berglund B, et al. Hypermobile ehlers-danlos syndrome (a.k.a. Ehlers-Danlos syndrome type III and ehlers-danlos syndrome hypermobility type): Clinical description and natural history. Am J Med Genet C Semin Med Genet 2017; 175(1): 48-69.
[http://dx.doi.org/10.1002/ajmg.c.31538] [PMID: 28145611]
[12]
Gensemer C, Burks R, Kautz S, Judge DP, Lavallee M, Norris RA. Hypermobile Ehlers‐Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes. Dev Dyn 2021; 250(3): 318-44.
[http://dx.doi.org/10.1002/dvdy.220] [PMID: 32629534]
[13]
Atwell K, Michael W, Dubey J, et al. Diagnosis and management of hypermobility spectrum disorders in primary care. J Am Board Fam Med 2021; 34(4): 838-48.
[http://dx.doi.org/10.3122/jabfm.2021.04.200374] [PMID: 34312277]
[14]
Micale L, Fusco C, Castori M. Ehlers-danlos syndromes, joint hypermobility and hypermobility spectrum disorders. Adv Exp Med Biol 2021; 1348: 207-33.
[http://dx.doi.org/10.1007/978-3-030-80614-9_9] [PMID: 34807421]
[15]
Tinkle BT, Levy HP. Symptomatic joint hypermobility. Med Clin North Am 2019; 103(6): 1021-33.
[http://dx.doi.org/10.1016/j.mcna.2019.08.002] [PMID: 31582002]
[16]
Thwaites PA, Gibson PR, Burgell RE. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know. J Gastroenterol Hepatol 2022; 37(9): 1693-709.
[http://dx.doi.org/10.1111/jgh.15927] [PMID: 35750466]
[17]
Teran-Wodzinski P, Kumar A. Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): An online survey. Rheumatol Int 2023; 43(10): 1935-45.
[http://dx.doi.org/10.1007/s00296-023-05378-3] [PMID: 37378685]
[18]
Hakim A, De Wandele I, O’Callaghan C, Pocinki A, Rowe P. Chronic fatigue in Ehlers-Danlos syndrome—Hypermobile type. Am J Med Genet C Semin Med Genet 2017; 175(1): 175-80.
[http://dx.doi.org/10.1002/ajmg.c.31542] [PMID: 28186393]
[19]
Fairweather D, Bruno KA, Darakjian AA, et al. High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities. Front Med 2023; 10: 1096180.
[http://dx.doi.org/10.3389/fmed.2023.1096180] [PMID: 37181352]
[20]
Song B, Yeh P, Harrell J. Systemic manifestations of Ehlers-Danlos syndrome. Proc Bayl Univ Med Cent 2021; 34(1): 49-53.
[http://dx.doi.org/10.1080/08998280.2020.1805714] [PMID: 33456144]
[21]
Khalil H, Rafi J, Hla TT. A case report of obstetrical management of a pregnancy with hypermobile Ehlers-Danlos syndrome and literature review. Obstet Med 2013; 6(2): 80-2.
[http://dx.doi.org/10.1177/1753495x13482894] [PMID: 27757162]
[22]
Gullapalli PA, Javed S. Multidisciplinary chronic pain management strategies in patients with Ehlers-Danlos syndromes. Pain Manag 2023; 13(1): 5-14.
[http://dx.doi.org/10.2217/pmt-2022-0050] [PMID: 36305215]
[23]
Jones JT, Black WR, Cogan W, Callen E. Resource utilization and multidisciplinary care needs for patients with Ehlers-Danlos syndrome. Mol Genet Genomic Med 2022; 10(11): e2057.
[http://dx.doi.org/10.1002/mgg3.2057] [PMID: 36151850]
[24]
Black WR, Jones JT, Rush ET, Malloy Walton L, Harding A. Development of a multidisciplinary clinic for patients with ehlers danlos syndromes: Considerations and strategies. J Multidiscip Healthc 2023; 16: 191-5.
[http://dx.doi.org/10.2147/JMDH.S396221] [PMID: 36714240]
[25]
Ahimaz P, Kramer T, Swaroop P, et al. Assessment of the beliefs, needs, and expectations for genetic counseling of patients with hypermobile Ehlers‐Danlos syndrome. Am J Med Genet A 2022; 188(11): 3172-83.
[http://dx.doi.org/10.1002/ajmg.a.62945] [PMID: 36209348]
[26]
Reychler G, De Backer MM, Piraux E, Poncin W, Caty G. Physical therapy treatment of hypermobile Ehlers-Danlos syndrome: A systematic review. Am J Med Genet A 2021; 185(10): 2986-94.
[http://dx.doi.org/10.1002/ajmg.a.62393] [PMID: 34145717]
[27]
Engelbert RHH, Juul-Kristensen B, Pacey V, et al. The evidence‐based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers Danlos syndrome. Am J Med Genet C Semin Med Genet 2017; 175(1): 158-67.
[http://dx.doi.org/10.1002/ajmg.c.31545] [PMID: 28306230]
[28]
Chopra P, Tinkle B, Hamonet C, et al. Pain management in the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 2017; 175(1): 212-9.
[http://dx.doi.org/10.1002/ajmg.c.31554] [PMID: 28186390]
[29]
Garreth Brittain M, Flanagan S, Foreman L, Teran-Wodzinski P. Physical therapy interventions in generalized hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome: A scoping review. Disabil Rehabil 2023; 1-18.
[http://dx.doi.org/10.1080/09638288.2023.2216028] [PMID: 37231592]
[30]
Jensen AM, Andersen JQ, Quisth L, Ramstrand N. Finger orthoses for management of joint hypermobility disorders: Relative effects on hand function and cognitive load. Prosthet Orthot Int 2021; 45(1): 36-45.
[http://dx.doi.org/10.1177/0309364620956866] [PMID: 33834743]
[31]
Buryk-Iggers S, Mittal N, Santa Mina D, et al. Exercise and rehabilitation in people with Ehlers-Danlos syndrome: A systematic review. Arch Rehab Res Clin Trans 2022; 4(2): 100189.
[http://dx.doi.org/10.1016/j.arrct.2022.100189] [PMID: 35756986]
[32]
Daman M, Shiravani F, Hemmati L, Taghizadeh S. The effect of combined exercise therapy on knee proprioception, pain intensity and quality of life in patients with hypermobility syndrome: A randomized clinical trial. J Bodyw Mov Ther 2019; 23(1): 202-5.
[http://dx.doi.org/10.1016/j.jbmt.2017.12.012] [PMID: 30691753]
[33]
Toprak Celenay S, Ozer Kaya D. Effects of spinal stabilization exercises in women with benign joint hypermobility syndrome: A randomized controlled trial. Rheumatol Int 2017; 37(9): 1461-8.
[http://dx.doi.org/10.1007/s00296-017-3713-6] [PMID: 28361275]
[34]
Hakimi A, Bergoin C, Mucci P. Immediate and 6‐week after effects of a rehabilitation program for Ehlers-Danlos syndrome hypermobile type patients: A retrospective study. Am J Med Genet A 2020; 182(10): 2263-71.
[http://dx.doi.org/10.1002/ajmg.a.61772] [PMID: 32738018]
[35]
Bieniak KH, Tinkle BT, Tran ST. The role of functional disability and social support in psychological outcomes for individuals with pediatric hypermobile Ehlers-Danlos syndrome. J Child Health Care 2022.
[http://dx.doi.org/10.1177/13674935221143822] [PMID: 36484120]
[36]
De Baets S, De Temmerman M, Calders P, et al. The impact of hypermobile “Ehlers-Danlos syndrome” and hypermobile spectrum disorder on interpersonal interactions and relationships. Front rehabil sci 2022; 3: 832806.
[http://dx.doi.org/10.3389/fresc.2022.832806] [PMID: 36188999]
[37]
Bulbena A, Baeza-Velasco C, Bulbena-Cabré A, et al. Psychiatric and psychological aspects in the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 2017; 175(1): 237-45.
[http://dx.doi.org/10.1002/ajmg.c.31544] [PMID: 28186381]
[38]
Baeza-Velasco C, Bourdon C, Montalescot L, et al. Low- and high-anxious hypermobile Ehlers-Danlos syndrome patients: Comparison of psychosocial and health variables. Rheumatol Int 2018; 38(5): 871-8.
[http://dx.doi.org/10.1007/s00296-018-4003-7] [PMID: 29497845]
[39]
Lattimore P, Harrison F. Pilot study of an online-delivered mindfulness meditation in Ehlers-Danlos syndrome (hEDS): Effect on quality-of-life and participant lived experience. Disabil Rehabil 2022; 1-8.
[http://dx.doi.org/10.1080/09638288.2022.2140843] [PMID: 36326346]
[40]
Berglund B, Pettersson C, Pigg M, Kristiansson P. Self-reported quality of life, anxiety and depression in individuals with Ehlers-Danlos syndrome (EDS): A questionnaire study. BMC Musculoskelet Disord 2015; 16(1): 89.
[http://dx.doi.org/10.1186/s12891-015-0549-7] [PMID: 25880527]
[41]
Pietri-Toro JM, Gardner OK, Leuchter JD, DiBartolomeo G, Hunter JA, Forghani I. Prevalence of cardiovascular manifestations in patients with hypermobile Ehlers‐Danlos syndrome at the University of Miami. Am J Med Genet A 2023; 191(6): 1502-7.
[http://dx.doi.org/10.1002/ajmg.a.63168] [PMID: 36866504]
[42]
Asher SB, Chen R, Kallish S. Mitral valve prolapse and aortic root dilation in adults with hypermobile Ehlers-Danlos syndrome and related disorders. Am J Med Genet A 2018; 176(9): 1838-44.
[http://dx.doi.org/10.1002/ajmg.a.40364] [PMID: 30063091]
[43]
Atzinger CL, Meyer RA, Khoury PR, Gao Z, Tinkle BT. Cross-sectional and longitudinal assessment of aortic root dilation and valvular anomalies in hypermobile and classic Ehlers-Danlos syndrome. J Pediatr 2011; 158(5): 826-830.e1.
[http://dx.doi.org/10.1016/j.jpeds.2010.11.023] [PMID: 21193204]
[44]
Paige SL, Lechich KM, Tierney ESS, Collins RT II. Cardiac involvement in classical or hypermobile Ehlers-Danlos syndrome is uncommon. Genet Med 2020; 22(10): 1583-8.
[http://dx.doi.org/10.1038/s41436-020-0856-8] [PMID: 32518415]
[45]
Wenstrup RJ, Meyer RA, Lyle JS, et al. Prevalence of aortic root dilation in the Ehlers-Danlos syndrome. Genet Med 2002; 4(3): 112-7.
[http://dx.doi.org/10.1097/00125817-200205000-00003] [PMID: 12180144]
[46]
Ritter A, Atzinger C, Hays B, et al. Natural history of aortic root dilation through young adulthood in a hypermobile Ehlers-Danlos syndrome cohort. Am J Med Genet A 2017; 173(6): 1467-72.
[http://dx.doi.org/10.1002/ajmg.a.38243] [PMID: 28436618]
[47]
Rauser-Foltz KK, Starr LJ, Yetman AT. Utilization of echocardiography in Ehlers‐Danlos syndrome. Congenit Heart Dis 2019; 14(5): 864-7.
[http://dx.doi.org/10.1111/chd.12824] [PMID: 31328377]
[48]
Sheldon RS, Grubb BP II, Olshansky B, et al. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm 2015; 12(6): e41-63.
[http://dx.doi.org/10.1016/j.hrthm.2015.03.029] [PMID: 25980576]
[49]
Tu Y, Abell TL, Raj SR, Mar PL. Mechanisms and management of gastrointestinal symptoms in postural orthostatic tachycardia syndrome. Neurogastroenterol Motil 2020; 32(12): e14031.
[http://dx.doi.org/10.1111/nmo.14031] [PMID: 33140561]
[50]
Cook GA Jr, Sandroni P. Management of headache and chronic pain in POTS. Auton Neurosci 2018; 215: 37-45.
[http://dx.doi.org/10.1016/j.autneu.2018.06.004] [PMID: 29929839]
[51]
Arnold AC, Ng J, Raj SR. Postural tachycardia syndrome - Diagnosis, physiology, and prognosis. Auton Neurosci 2018; 215: 3-11.
[http://dx.doi.org/10.1016/j.autneu.2018.02.005] [PMID: 29523389]
[52]
Fu Q, Levine BD. Exercise and non-pharmacological treatment of POTS. Auton Neurosci 2018; 215: 20-7.
[http://dx.doi.org/10.1016/j.autneu.2018.07.001] [PMID: 30001836]
[53]
Sebastian SA, Co EL, Panthangi V, et al. Postural orthostatic tachycardia syndrome (POTS): An update for clinical practice. Curr Probl Cardiol 2022; 47(12): 101384.
[http://dx.doi.org/10.1016/j.cpcardiol.2022.101384] [PMID: 36055438]
[54]
Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1. Auton Neurosci 2021; 235: 102828.
[http://dx.doi.org/10.1016/j.autneu.2021.102828] [PMID: 34144933]
[55]
Chen G, Du J, Jin H, Huang Y. Postural tachycardia syndrome in children and adolescents: Pathophysiology and clinical management. Front Pediatr 2020; 8: 474.
[http://dx.doi.org/10.3389/fped.2020.00474] [PMID: 32974246]
[56]
Zhang Q, Xu B, Du J. Update of individualized treatment strategies for postural orthostatic tachycardia syndrome in children. Front Neurol 2020; 11: 525.
[http://dx.doi.org/10.3389/fneur.2020.00525] [PMID: 32655482]
[57]
Shaw BH, Stiles LE, Bourne K, et al. The face of postural tachycardia syndrome - insights from a large cross‐sectional online community‐based survey. J Intern Med 2019; 286(4): 438-48.
[http://dx.doi.org/10.1111/joim.12895] [PMID: 30861229]
[58]
Miller AJ, Stiles LE, Sheehan T, et al. Prevalence of hypermobile Ehlers-Danlos syndrome in postural orthostatic tachycardia syndrome. Auton Neurosci 2020; 224: 102637.
[http://dx.doi.org/10.1016/j.autneu.2020.102637] [PMID: 31954224]
[59]
Deb A, Morgenshtern K, Culbertson CJ, Wang LB, Hohler AD. A survey-based analysis of symptoms in patients with postural orthostatic tachycardia syndrome. Proc Bayl Univ Med Cent 2015; 28(2): 157-9.
[http://dx.doi.org/10.1080/08998280.2015.11929217] [PMID: 25829642]
[60]
McDonald C, Koshi S, Busner L, Kavi L, Newton JL. Postural tachycardia syndrome is associated with significant symptoms and functional impairment predominantly affecting young women: A UK perspective. BMJ Open 2014; 4(6): e004127.
[http://dx.doi.org/10.1136/bmjopen-2013-004127] [PMID: 24934205]
[61]
Hakim AJ, Grahame R. Non-musculoskeletal symptoms in joint hypermobility syndrome. Indirect evidence for autonomic dysfunction? Br J Rheumatol 2004; 43(9): 1194-5.
[http://dx.doi.org/10.1093/rheumatology/keh279] [PMID: 15317957]
[62]
Boris JR, Moak JP. Pediatric postural orthostatic tachycardia syndrome: Where we stand. Pediatrics 2022; 150(1): e2021054945.
[http://dx.doi.org/10.1542/peds.2021-054945] [PMID: 35773520]
[63]
Rowe PC, Barron DF, Calkins H, Maumenee IH, Tong PY, Geraghty MT. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. J Pediatr 1999; 135(4): 494-9.
[http://dx.doi.org/10.1016/S0022-3476(99)70173-3] [PMID: 10518084]
[64]
Boris JR, Bernadzikowski T. Demographics of a large paediatric postural orthostatic tachycardia syndrome program. Cardiol Young 2018; 28(5): 668-74.
[http://dx.doi.org/10.1017/S1047951117002888] [PMID: 29357955]
[65]
De Wandele I, Rombaut L, Leybaert L, et al. Dysautonomia and its underlying mechanisms in the hypermobility type of Ehlers-Danlos syndrome. Semin Arthritis Rheum 2014; 44(1): 93-100.
[http://dx.doi.org/10.1016/j.semarthrit.2013.12.006] [PMID: 24507822]
[66]
Meeus W, Iedema J, Helsen M, Vollebergh W. Patterns of adolescent identity development: Review of literature and longitudinal analysis. Dev Rev 1999; 19(4): 419-61.
[http://dx.doi.org/10.1006/drev.1999.0483]
[67]
Gazit Y, Nahir AM, Grahame R, Jacob G. Dysautonomia in the joint hypermobility syndrome. Am J Med 2003; 115(1): 33-40.
[http://dx.doi.org/10.1016/S0002-9343(03)00235-3] [PMID: 12867232]
[68]
Hakim A, O’Callaghan C, De Wandele I, Stiles L, Pocinki A, Rowe P. Cardiovascular autonomic dysfunction in Ehlers-danlos syndrome—hypermobile type. Am J Med Genet C Semin Med Genet 2017; 175(1): 168-74.
[http://dx.doi.org/10.1002/ajmg.c.31543] [PMID: 28160388]
[69]
Dipaola F, Barberi C, Castelnuovo E, et al. Time course of autonomic symptoms in postural orthostatic tachycardia syndrome (pots) patients: Two-year follow-up results. Int J Environ Res Public Health 2020; 17(16): 5872.
[http://dx.doi.org/10.3390/ijerph17165872] [PMID: 32823577]
[70]
Kimpinski K, Figueroa JJ, Singer W, et al. A prospective, 1-year follow-up study of postural tachycardia syndrome. Mayo Clin Proc 2012; 87(8): 746-52.
[http://dx.doi.org/10.1016/j.mayocp.2012.02.020] [PMID: 22795533]
[71]
Medicine Io. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: Redefining an Illness. In: Washington, DC: The National Academies Press 2015; p. 304.
[72]
Bested AC, Marshall LM. Review of myalgic encephalomyelitis/chronic fatigue syndrome: An evidence-based approach to diagnosis and management by clinicians. Rev Environ Health 2015; 30(4): 223-49.
[http://dx.doi.org/10.1515/reveh-2015-0026] [PMID: 26613325]
[73]
Boris JR, Bernadzikowski T. Prevalence of joint hypermobility syndromes in pediatric postural orthostatic tachycardia syndrome. Auton Neurosci 2021; 231: 102770.
[http://dx.doi.org/10.1016/j.autneu.2020.102770] [PMID: 33388686]
[74]
Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: A refined and abbreviated composite autonomic symptom score. Mayo Clin Proc 2012; 87(12): 1196-201.
[http://dx.doi.org/10.1016/j.mayocp.2012.10.013] [PMID: 23218087]
[75]
Rea NA, Campbell CL, Cortez MM. Quantitative assessment of autonomic symptom burden in Postural tachycardia syndrome (POTS). J Neurol Sci 2017; 377: 35-41.
[http://dx.doi.org/10.1016/j.jns.2017.03.032] [PMID: 28477704]
[76]
Bhatia R, Kizilbash SJ, Ahrens SP, et al. Outcomes of adolescent-onset postural orthostatic tachycardia syndrome. J Pediatr 2016; 173: 149-53.
[http://dx.doi.org/10.1016/j.jpeds.2016.02.035] [PMID: 26979650]
[77]
De Wandele I, Calders P, Peersman W, et al. Autonomic symptom burden in the hypermobility type of Ehlers-Danlos syndrome: A comparative study with two other EDS types, fibromyalgia, and healthy controls. Semin Arthritis Rheum 2014; 44(3): 353-61.
[http://dx.doi.org/10.1016/j.semarthrit.2014.05.013] [PMID: 24968706]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy